Seres Therapeutics Aktie
0,32
EUR
-0,36
EUR
-52,97
%
0,37
USD
±0,00
USD
+1,32
%
Werbung
Seres Therapeutics Aktie Analyse
22.10.18 | Seres Therapeutics Buy | Chardan Capital Markets | |
13.10.17 | Seres Therapeutics Outperform | Oppenheimer & Co. Inc. | |
04.08.17 | Seres Therapeutics Buy | H.C. Wainwright & Co. | |
01.02.17 | Seres Therapeutics Outperform | FBR & Co. | |
30.03.16 | Seres Therapeutics Outperform | FBR Capital | |
25.01.16 | Seres Therapeutics Buy | H.C. Wainwright & Co. | |
22.07.15 | Seres Therapeutics Buy | Canaccord Adams |
Werbung
Werbung